AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study

Conditions:   Osteoarthritis;   Arthritis;   Avascular Necrosis;   Fracture of the Femoral Neck or Head;   Congenital Hip Dysplasia
Intervention:   Device: AMIStem Hip System
Sponsor:   Medacta International SA
Recruiting - verified April 2016

http://ift.tt/2nP0soV